Showing 1 - 12 results of 12 for search 'James J Driscoll', query time: 0.04s Refine Results
  1. 1
    A review of recent clinical trials to evaluate disease-modifying therapies in the treatment of cardiac amyloidosis

    A review of recent clinical trials to evaluate disease-modifying therapies in the treatment of cardiac amyloidosis by Sindhuja Senigarapu, James J. Driscoll, James J. Driscoll, James J. Driscoll

    Published 2024-10-01
    Get full text
    Article
  2. 2
    Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma

    Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma by Priyanka S. Rana, Priyanka S. Rana, Krishna Goparaju, Krishna Goparaju, James J. Driscoll, James J. Driscoll, James J. Driscoll

    Published 2023-06-01
    Get full text
    Article
  3. 3
    Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction

    Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction by Priyanka S. Rana, Priyanka S. Rana, David C. Soler, Jeries Kort, Jeries Kort, Jeries Kort, James J. Driscoll, James J. Driscoll, James J. Driscoll

    Published 2022-12-01
    Get full text
    Article
  4. 4
    Targeting Proteasomes in Cancer and Infectious Disease: A Parallel Strategy to Treat Malignancies and Microbes

    Targeting Proteasomes in Cancer and Infectious Disease: A Parallel Strategy to Treat Malignancies and Microbes by James J. Ignatz-Hoover, James J. Ignatz-Hoover, James J. Ignatz-Hoover, Elena V. Murphy, James J. Driscoll, James J. Driscoll, James J. Driscoll

    Published 2022-07-01
    Get full text
    Article
  5. 5
    Road testing new CAR design strategies in multiple myeloma

    Road testing new CAR design strategies in multiple myeloma by Priyanka S. Rana, Elena V. Murphy, Jeries Kort, Jeries Kort, James J. Driscoll, James J. Driscoll

    Published 2022-08-01
    Get full text
    Article
  6. 6
    Mechanistic and Treatment Implications of ΔNp63 Expression in a Rare Case of Metastatic Hidradenocarcinoma

    Mechanistic and Treatment Implications of ΔNp63 Expression in a Rare Case of Metastatic Hidradenocarcinoma by James J. Driscoll, Steven Gauerke, Brian C. Monahan

    Published 2009-03-01
    Get full text
    Article
  7. 7
    Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma

    Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma by Muthulekha Swamydas, Elena V. Murphy, James J. Ignatz-Hoover, Ehsan Malek, James J. Driscoll

    Published 2022-02-01
    Get full text
    Article
  8. 8
    Rare Extraperitoneal Involvement with Fatal Outcome in a Case of Bilateral Luteinized Thecoma of the Ovaries with Sclerosing Peritonitis

    Rare Extraperitoneal Involvement with Fatal Outcome in a Case of Bilateral Luteinized Thecoma of the Ovaries with Sclerosing Peritonitis by Mohamed A. Medhat, Mohamed A. Y. Abdel Malek, Saad Zaki, Ahmed Helmy, James J. Driscoll

    Published 2014-01-01
    Get full text
    Article
  9. 9
    Novel therapies emerging in oncology to target the TGF-β pathway

    Novel therapies emerging in oncology to target the TGF-β pathway by Byung-Gyu Kim, Ehsan Malek, Sung Hee Choi, James J. Ignatz-Hoover, James J. Driscoll

    Published 2021-04-01
    Get full text
    Article
  10. 10
    Transcriptional repression of Bim by a novel YY1-RelA complex is essential for the survival and growth of Multiple Myeloma.

    Transcriptional repression of Bim by a novel YY1-RelA complex is essential for the survival and growth of Multiple Myeloma. by Veena Potluri, Sunil K Noothi, Subrahmanya D Vallabhapurapu, Sang-Oh Yoon, James J Driscoll, Charles H Lawrie, Sivakumar Vallabhapurapu

    Published 2013-01-01
    Get full text
    Article
  11. 11
    The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial

    The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial by Ehsan Malek, Priyanka S. Rana, Muthulekha Swamydas, Michael Daunov, Masaru Miyagi, Elena Murphy, James J. Ignatz-Hoover, Leland Metheny, Seong Jin Kim, James J. Driscoll

    Published 2024-08-01
    Get full text
    Article
  12. 12
    Synthesis, Structural Characterization, and Preclinical Efficacy of a Novel Paclitaxel-Loaded Alginate Nanoparticle for Breast Cancer Treatment

    Synthesis, Structural Characterization, and Preclinical Efficacy of a Novel Paclitaxel-Loaded Alginate Nanoparticle for Breast Cancer Treatment by Ahmed A. Markeb, Nagwa A. El-Maali, Douaa M. Sayed, Amany Osama, Mohamed A. Y. Abdel-Malek, Amen H. Zaki, Mostafa E. A. Elwanis, James J. Driscoll

    Published 2016-01-01
    Get full text
    Article

Search Tools: